首页> 外文会议>Annual International Conference of the IEEE Engineering in Medicine and Biology Society >Optimal decision support rules improve personalize warfarin treatment outcomes
【24h】

Optimal decision support rules improve personalize warfarin treatment outcomes

机译:最佳决策支持规则改善个性化华法素治疗结果

获取原文

摘要

We tested optimization-based approaches to generate decision support rules used to improve personalized warfarin treatment based on clinical and genetic characteristics. Our approach simulated warfarin treatment outcomes using five existing treatment plans for clinical avatars (virtual patients). We used individual clinical avatar Time-in-Therapeutic-Range to represent the two-sided adverse risk to bleeding (over dosed - above therapeutic range) and thrombosis (under dosed - below therapeutic range) and as the objective function in the optimization to minimize overall risk. A series of optimization approaches demonstrate that correctly selected decision rules matched to particularly characterized patients produce treatment plans that minimize risk. Finally, a decision tree algorithm was used to produce decision rules, each of which indicated a specific treatment plan that optimally reduce risks for a patient subgroup. The optimization approach minimizes entropy/impurity property thus producing rules that identify treatment plans that minimize overall adverse risks for the largest possible patient subgroups.
机译:我们测试了基于优化的方法,以产生基于临床和遗传特征来改善个性化Warfarin治疗的决策支持规则。我们的方法模拟了使用五个临床头像(虚拟患者)现有治疗计划的华法林治疗结果。我们使用单独的临床头像时间急性范围,以代表渗出(过度治疗范围)和血栓形成(在低于治疗范围内)的双面不良风险,并作为优化中的目标函数最小化总体风险。一系列优化方法证明了与特别是特征的患者匹配的正确选择的决策规则产生最小化风险的治疗计划。最后,使用决策树算法来产生决策规则,每个决策规则指示了最佳地降低患者子组的风险的特定治疗计划。优化方法可最大限度地减少熵/杂质属性,从而制定识别识别最大限度的治疗计划的规则,以最大限度地降低最大可能的患者亚组的整体不利风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号